Delivery Order SPE2DB22D1106-SPE2DB24FFKT9
Award Date
9/3/24
Potential Completion Date
9/24/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of VYEPTI 100 MG/ML VIALML, a medical product, with a ceiling value of $8,100.26 and a period of performance through July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Vyepti 100 mg/mL vials, a specialty pharmaceutical medication. The contract has a ceiling value of $2,314.36 and a period of performance ending on June 13, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,135.02 award is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, with a performance period through March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.72 firm fixed price contract is for the supply of VYEPTI 100 MG/ML VIALML, with a performance period ending on July 14, 2025. Amerisourcebergen Drug Corp is not a small business, as the contract is not set aside. The company holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYEPTI 100 MG/ML VIALML. The contract has a firm fixed price of $28,929.50 and a completion date of July 16, 2025. It is not a set-aside contract, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VYEPTI 100 MG/ML VIALML pharmaceutical products, with a potential value of $1,047.01 and a completion date of January 19, 2024. The award date was December 27, 2023. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp, as a prime contractor,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Vyepti 100 mg/ml vials, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,471.54 and a performance period through July 3, 2025. The contract is not set aside and was awarded on June 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
This federal contract award, with the ID SPE2DB24D1205|SPE2DB25FCVMX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,943.08 Firm Fixed Price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 24, 2025 and does not have a set-aside designation, indicating open...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $12,792.51. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with an Ultimate Completion Date of June 17, 2025. The contract is not set aside and allows for open competition....
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, a delivery order contract worth $35,965.17 for the supply of 400 mg/20 ml vials of the medication VYVGART. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...